Platform    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
13Multiple sclerosis/Neuromyelitis optica3

13. Multiple sclerosis/Neuromyelitis optica    [ 3,050 clinical trials,   2,147 drugs,   (DrugBank: 348 drugs),   244 drug target genes,   228 drug target pathways]
Searched query = "Multiple sclerosis/Neuromyelitis optica", "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
3 / 3,050 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04387734
(ClinicalTrials.gov)
December 202011/5/2020Effects of Ocrevus in Relapsing Multiple SclerosisEffects and Mechanisms of Ocrevus on Ambulatory Functions in People With Relapsing Multiple SclerosisRelapsing Multiple SclerosisDrug: Ocrelizumab;Drug: PlatformGeorgia State UniversityMultiple Sclerosis Center of AtlantaNot yet recruiting18 Years55 YearsAll60Phase 4United States
2NCT03353974
(ClinicalTrials.gov)
December 1, 201716/11/2017Video Games Therapy on Balance and Cognitive Functions in Mild to Moderate Impaired Multiple Sclerosis Patients.The Role of Video Games Therapy on Balance and Cognitive Functions in Mild to Moderate Impaired Multiple Sclerosis Patients. A Pilot Randomized Controlled Trial.Multiple SclerosisDevice: Video game therapy;Device: Balance platform therapyUniversity Hospital of FerraraNULLRecruiting18 Years80 YearsAll40N/AItaly
3NCT04289675
(ClinicalTrials.gov)
January 1, 201227/12/2019Multiple Sclerosis: Chi3L1 and Treatment EfficacyChi3L1: A Marker of Efficacy of Platform Treatments in Relapsing-onset Multiple Sclerosis: A Prognostic Study on Existing Clinical Data and Biological SamplesMultiple SclerosisDrug: Interferon-BetaCentral Hospital, Nancy, FranceNULLCompleted18 Years55 YearsAll63NULL